US Patent 7220729 Huntington's Disease Treatment
Patent 7220729 was granted and assigned to Academia Sinica on May, 2007 by the United States Patent and Trademark Office.
All edits
Edits on 6 Sep, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Inventor Names
Yijuang Chern0
Edits on 1 Sep, 2023
Golden AI
Edits made to:
Article (+332 characters)
Article
Patent abstract
A method of identifying a 5′AMP-activated protein kinase inhibitor for treating a neurodegenerative disease. Disclosed are a method and a packaged product for treating a neurodegenerative disease. Also disclosed is a method for treating a 5′AMP-activated protein kinase-related disease and a related packaged product.
Edits on 25 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 23 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07220729 Huntington's Disease Treatment US Patent 7220729 Huntington's Disease Treatment
Infobox
Patent Number
072207290
Patent Number
72207290
Edits on 25 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
072207290
Date of Patent
May 22, 2007
0Patent Application Number
108432090
Date Filed
May 10, 2004
0Official Website
Patent Primary Examiner
Edits on 15 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 21 Nov, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07220729 Huntington's Disease Treatment
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07220729
Date of patent
May 22, 2007
Patent application number
10843209
Date Filed
May 10, 2004
Patent primary examiner
Find more entities like US Patent 7220729 Huntington's Disease Treatment
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
